The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain

Recent Results Cancer Res. 1996:141:183-92. doi: 10.1007/978-3-642-79952-5_13.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Astrocytoma / radiotherapy
  • Brain Neoplasms / radiotherapy*
  • ErbB Receptors / immunology*
  • Glioblastoma / radiotherapy
  • Glioma / radiotherapy*
  • Humans
  • Immunoconjugates / administration & dosage
  • Immunoconjugates / therapeutic use*
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / therapeutic use
  • Injections, Intravenous
  • Iodine Radioisotopes / administration & dosage
  • Iodine Radioisotopes / therapeutic use*
  • Middle Aged
  • Neoplasm Recurrence, Local / radiotherapy
  • Radioimmunotherapy*
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Survival Rate

Substances

  • Antibodies, Monoclonal
  • Immunoconjugates
  • Immunoglobulin G
  • Iodine Radioisotopes
  • ErbB Receptors